Peninsula biotech spins out parasite-fighting drugs to biotech legends' startup
A Peninsula biotech company is supplying a set of parasite-fighting preclinical compounds to a startup created by one of the scientists who co-founded the company more than two decades ago. Kainomyx Inc. — launched by a Stanford University-connected team including scientist Jim Spudich, a winner of the prestigious Lasker Award — is targeting malaria, leishmaniasis and other parasitic diseases. Spudich was one of the founders of Cytokinetics Inc. (NASDAQ: CYTK), which is taking an equity stake… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - July 13, 2020 Category: Pharmaceuticals Authors: Ron Leuty Source Type: news

Nigeria: Kano Government, Malaria Consortium to Spend N3illion On Prevention Campaign
[Daily Trust] Kano State Government in partnership with the Malaria Consortium have earmarked about N3 billion for malaria prevention activities in the state. (Source: AllAfrica News: Malaria)
Source: AllAfrica News: Malaria - July 13, 2020 Category: Infectious Diseases Source Type: news

The Lancet Global Health: Modelling study predicts surge in HIV, TB, and malaria deaths due to COVID-19 pandemic
(The Lancet) Some low- and middle-income countries (LMICs) could see HIV, tuberculosis (TB), and malaria deaths increase by as much as 10%, 20%, and 36% respectively over the next 5 years due to the disruption of health services caused by the COVID-19 pandemic and its response, according new modelling research published in The Lancet Global Health journal. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - July 13, 2020 Category: Infectious Diseases Source Type: news

Nigeria: COVID-19 - Group Cautions Against Retrogression in Anti Malaria Drive
[This Day] Abuja -- The Civil Society in Malaria Control, Immunisation and Nutrition (ACOMIN) national advocacy group has said that Nigeria is witnessing a slowing down in intervention efforts against malaria scourge due to the attention being focused on containing COVID-19. (Source: AllAfrica News: Malaria)
Source: AllAfrica News: Malaria - July 9, 2020 Category: Infectious Diseases Source Type: news

Landcent seeks €2 million investment into next generation of malaria prevention products
The initiative aims to accelerate the World Health Organisation ’s goal of a malaria-free world by 2040. (Source: mobihealthnews)
Source: mobihealthnews - July 9, 2020 Category: Information Technology Source Type: news

Ghana: Malaria Elimination At Risk As Ghana Economy Improves
[SciDev.Net] Accra -- Ghana's efforts to eliminate malaria could be in jeopardy as its improved economy results in reduced external funding for fighting malaria, a study suggests. (Source: AllAfrica News: Malaria)
Source: AllAfrica News: Malaria - July 9, 2020 Category: Infectious Diseases Source Type: news

Africa: Next Generation Entomologists Share Their Research in Malaria Consortium Webinar
[Malaria Consortium] Since 2017, seven exceptional students from across Africa and Asia have received Malaria Consortium's Dr Sylvia Meek Scholarship in Entomology. As many of the scholars' studies have drawn to a close, they were given the chance to present their research projects during a Malaria Consortium webinar: 'The next generation of entomologists: What the future holds'. (Source: AllAfrica News: Malaria)
Source: AllAfrica News: Malaria - July 9, 2020 Category: Infectious Diseases Source Type: news

Should We Experimentally Infect People With Covid-19 To Speed Up Vaccine Development?
Dr. Stephen Thomas, Chief of Infectious Diseases at SUNY Upstate Medical University, discusses his experience volunteering for a malaria vaccine trial in 2001 and how to evaluate the risks of human challenge experiments in search of a coronavirus vaccine. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - July 8, 2020 Category: Pharmaceuticals Authors: Stephen Thomas, Contributor Tags: Healthcare /healthcare Innovation /innovation Science /science Editors' Pick editors-pick Decision Maker decision-maker Coronavirus Source Type: news

Brazil's president, infected with virus, touts malaria drug
Brazilian President Jair Bolsonaro, who says he is infected with the coronavirus, has defended his government’s handling of the pandemic that has killed tens of thousands of Brazilians and touted his use of a contentious anti-malaria drug (Source: ABC News: Health)
Source: ABC News: Health - July 8, 2020 Category: Consumer Health News Tags: Health Source Type: news

‘I Trust Hydroxychloroquine.’ Brazil’s President Jair Bolsonaro Says He’s Taking Controversial Anti-Malaria Drug to Cure Coronavirus
(RIO DE JANEIRO) — Brazilian President Jair Bolsonaro says he is confident that he will swiftly recover from the new coronavirus thanks to treatment with hydroxychloroquine, the anti-malaria drug that has not been proven effective against COVID-19. Bolsonaro said he tested positive for the new coronavirus on Tuesday after months of downplaying its severity while deaths mounted rapidly inside the country. The president told reporters he underwent a lung X-ray on Monday after experiencing fever, muscle aches and malaise. As of Tuesday, his fever had subsided, he said, and he attributed the improvement to hydroxychloroq...
Source: TIME: Health - July 8, 2020 Category: Consumer Health News Authors: Marcelo De Sousa and David Biller / AP Tags: Uncategorized brazil COVID-19 News Desk wire Source Type: news

Brazil's president says hydroxychloroquine to cure his virus
Brazilian President Jair Bolsonaro says he is confident that he will swiftly recover from the new coronavirus thanks to treatment with hydroxychloroquine, the anti-malaria drug that has not been proven effective against COVID-19 (Source: ABC News: Health)
Source: ABC News: Health - July 8, 2020 Category: Consumer Health News Tags: Health Source Type: news

Henry Ford health study finds hydroxychloroquine to be effective against COVID-19
(Natural News) Yet another peer-reviewed research paper has demonstrated that the generic anti-malaria drug hydroxychloroquine, when used appropriately, can help to effectively treat Wuhan coronavirus (COVID-19) patients. Published by the Henry Ford Health System in Michigan, the study used a large-scale retrospective analysis of patients examined between March 10 and May 2. It looked at... (Source: NaturalNews.com)
Source: NaturalNews.com - July 7, 2020 Category: Consumer Health News Source Type: news

Brazil ’s President Jair Bolsonaro Tests Positive for Coronavirus But Says He Feels ‘Perfectly Well’
Brazil President Jair Bolsonaro tested positive for Covid-19 in an escalation of the health crisis that has engulfed Latin America’s largest economy. “I’m perfectly well,” Bolsonaro told CNN Brasil in a live interview, after announcing the result of his test. He added he is taking hydroxychloroquine, an anti-malaria medicine he’s been touting as being effective against the virus though its use hasn’t been authorized by most health experts globally and could carry dangerous side effects. The 65-year-old president, who during his campaign to reopen the economy called the virus “just ...
Source: TIME: Health - July 7, 2020 Category: Consumer Health News Authors: Simone Iglesias and Murilo Fagundes / Bloomberg Tags: Uncategorized brazil COVID-19 News Desk wire Source Type: news

WHO Halts Hydroxychloroquine, HIV Drugs in COVID Trials After Failure to Reduce Death WHO Halts Hydroxychloroquine, HIV Drugs in COVID Trials After Failure to Reduce Death
WHO said on Saturday that it was discontinuing its trials of the malaria drug hydroxychloroquine and combination HIV drug lopinavir/ritonavir in hospitalised patients with COVID-19 after they failed to reduce mortality.Reuters Health Information (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - July 7, 2020 Category: Infectious Diseases Tags: Infectious Diseases News Source Type: news

Coronavirus: Hydroxychloroquine trialled over better treatments
About 200 of 1,200 clinical trials looked at anti-malaria drug hydroxychloroquine as a potential treatment for coronavirus, but fewer than 25 studies examined dexamethasone or remdesivir. (Source: the Mail online | Health)
Source: the Mail online | Health - July 6, 2020 Category: Consumer Health News Source Type: news

Hydroxychloroquine given to 300k more patients than usual
A new study from the CDC found that between February 2020 and March 2020, prescriptions for the anti-malaria drug hydroxychloroquine increase by 86.2% from 367, 346 to 683,999. (Source: the Mail online | Health)
Source: the Mail online | Health - July 6, 2020 Category: Consumer Health News Source Type: news

Prescriptions for two malaria drugs more than doubled early in COVID-19 outbreak, CDC says
Prescriptions for chloroquine and hydroxychloroquine rose 159 percent and 86 percent, respectively, across the United States in February and March -- the early days on the COVID-19 outbreak, according to a CDC analysis. (Source: Health News - UPI.com)
Source: Health News - UPI.com - July 6, 2020 Category: Consumer Health News Source Type: news

Hydroxychloroquine prescribed to 300,000 more patients than usual after Trump endorsement
A new study from the CDC found that between February 2020 and March 2020, prescriptions for the anti-malaria drug hydroxychloroquine increase by 86.2% from 367, 346 to 683,999. (Source: the Mail online | Health)
Source: the Mail online | Health - July 6, 2020 Category: Consumer Health News Source Type: news

Stop TB Partnership and Johnson & Johnson, with support from USAID and The Global Fund, Announce Price Reduction for SIRTURO ® (bedaquiline) for Treatment of Drug-Resistant Tuberculosis in Low- and Middle-Income Countries
GENEVA, SWITZERLAND, 6 JULY 2020 – The Stop TB Partnership and Johnson & Johnson – with support from the Global Fund to Fight AIDS, TB and Malaria, and the U.S. Agency for International Development (USAID) – today announced joint efforts to help enable low- and middle-income countries to rapidly scale up use of SIRTURO® (bedaquiline) 100mg tablets in support of new, recently-released World Health Organization (WHO) treatment guidelines. Effective immediately, Johnson & Johnson will make bedaquiline available to Stop TB Partnership’s Global Drug Facility (GDF) at a price of USD$340 per si...
Source: Johnson and Johnson - July 6, 2020 Category: Pharmaceuticals Tags: Innovation Source Type: news

WHO says trials show malaria and HIV drugs don't cut Covid-19 hospital deaths
Hydroxychloroquine and lopinavir/ritonavir not found to help patients in hospitalCoronavirus – latest updatesSee all our coronavirus coverageThe World Health Organization (WHO) said on Saturday that it was discontinuing its trials of the malaria drughydroxychloroquine and combination HIV drug lopinavir/ritonavir for patients in hospital with Covid-19 after they failed to reduce mortality.The setback came as WHO also reported more than 200,000 new cases globally of the disease for the first time in a single day. The US accounted for 53,213 of the total 212,326 new cases recorded on Friday, the WHO said.Continue readin...
Source: Guardian Unlimited Science - July 4, 2020 Category: Science Authors: Reuters Tags: Coronavirus outbreak Medical research World Health Organization World news US news Pharmaceuticals industry Science Infectious diseases Source Type: news

Rohingya refugee crisis: “I want to be educated and become a doctor”
Doctors of the World/Médecins du Monde is responding to COVID-19 in the sprawling refugee camps of Cox’s Bazar, southeastern Bangladesh, which are home to about one million Rohingya refugees. Our teams work with Rohingya volunteers and our local partner PULSE Bangladesh to improve healthcare in the camps and raise awareness about COVID-19 so that residents can protect themselves. Tasmin (not her real name) is a young Rohingya woman who has volunteered as a youth educator. She shared her story with us, just prior to COVID-19’s arrival in Cox’s Bazar. “We Rohingya are a minority ethnic...
Source: Doctors of the World News - July 3, 2020 Category: International Medicine & Public Health Authors: Kim Vlasic Tags: Uncategorised COVID-19 health promotion refugee camp refugees Rohingya Rohingya refugee crisis testimony Source Type: news

Nigeria: Madagascar's COVID-19 Mixture Contains Mainly Anti-Malaria Components - Health Minister
[Premium Times] Findings from the analysis of COVID Organics shows that it largely contains anti-malaria components, the Minister of Health, Osagie Ehanire, said on Thursday. (Source: AllAfrica News: Malaria)
Source: AllAfrica News: Malaria - July 3, 2020 Category: Infectious Diseases Source Type: news

Getting a grasp on India's malaria burden
(Kyoto University) A new approach could illuminate a critical stage in the life cycle of one of the most common malaria parasites. The approach was developed by scientists at Kyoto University's Institute for Integrated Cell-Material Sciences (iCeMS) in Japan and published in the Malaria Journal. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 3, 2020 Category: International Medicine & Public Health Source Type: news

Coronavirus: Sniffer dogs trial going 'very well'
The bio-detection dogs are already trained to detect odours of cancers, malaria and Parkinson's disease. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - July 3, 2020 Category: Consumer Health News Source Type: news

Namibia: Kavango Regions Record Nearly 7 000 Malaria Cases
[New Era] Cecilia Iyambo (Source: AllAfrica News: Malaria)
Source: AllAfrica News: Malaria - July 2, 2020 Category: Infectious Diseases Source Type: news

This Scientist Is Searching For A Vaccine To World ’s Second-Most Devastating Parasite
Amanda Elyssa Ruiz, a PhD student at Brown University, is looking for potential vaccines to protect against schistosomiasis, a disease that impacts over 250 million people every year, making it the second most socio-economically devastating parasitic disease after malaria. #globalsouthscience (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - July 2, 2020 Category: Pharmaceuticals Authors: Andrew Wight, Contributor Tags: Science /science Innovation /innovation Healthcare /healthcare Leadership /leadership ForbesWomen /forbeswomen Editors' Pick editors-pick Decision Maker decision-maker Source Type: news

Sierra Leone: Sierra Leone Tackling Malaria Amidst COVID-19 Outbreak Response
[WHO] Mass distribution of long-lasting insecticide treated bed nets is underway in Sierra Leone's capital city, Freetown and its suburbs to complete a nationwide household distribution of 4.6 million mosquito nets. The campaign started in mid-May with nets distributed in 14 of the country's 16 districts. The remaining two districts (Western Area Urban and Western Area Rural), in the capital and its suburbs account for around a fifth of the 7-million population and has also been accounting for nearly 60% of the (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - July 2, 2020 Category: African Health Source Type: news

Global COVID-19 Prevention Trial of Hydroxychloroquine to Resume Global COVID-19 Prevention Trial of Hydroxychloroquine to Resume
A global trial designed to test whether the anti-malaria drugs hydroxychloroquine and chloroquine can prevent infection with COVID-19 is to restart after being approved by British regulators.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 30, 2020 Category: Consumer Health News Tags: Infectious Diseases News Source Type: news

Malaria's secret to surviving in the blood uncovered
(The Francis Crick Institute) New research from the Francis Crick Institute has found how the malaria parasite protects itself from toxic compounds in red blood cells. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - June 30, 2020 Category: Biology Source Type: news

Nigeria: Deaths From HIV, TB and Malaria Could Double in 12 Months - Report
[Premium Times] A new report has shown that deaths from HIV, tuberculosis, and malaria could double if systems for health are overwhelmed, treatment and prevention programmes are disrupted and resources are diverted. (Source: AllAfrica News: HIV-Aids and STDs)
Source: AllAfrica News: HIV-Aids and STDs - June 26, 2020 Category: Infectious Diseases Source Type: news

How Deforestation Helps Deadly Viruses Jump from Animals to Humans
This article is republished from The Conversation under a Creative Commons license. Read the original article. The post How Deforestation Helps Deadly Viruses Jump from Animals to Humans appeared first on Inter Press Service. (Source: IPS Inter Press Service - Health)
Source: IPS Inter Press Service - Health - June 26, 2020 Category: International Medicine & Public Health Authors: External Source Tags: Environment Global Headlines Health TerraViva United Nations Source Type: news

Nigeria: Groups Embark On Fumigation to Tackle Malaria
[Daily Trust] Damaturu -The Humanitarian Network for Northern Nigeria(HNNN), in collaboration with the Women in Sahel Initiative (WISI), has embarked on environmental fumigation in local communities of Potiskum metropolis. (Source: AllAfrica News: Malaria)
Source: AllAfrica News: Malaria - June 26, 2020 Category: Infectious Diseases Source Type: news

Sierra Leone: Mass Distribution of Bed Net in Freetown
[Concord] The mass distribution campaign of treated bed nets and House to House Family Sensitization on Covid-19 prevention are underway in the Western Area of Sierra Leone. (Source: AllAfrica News: Malaria)
Source: AllAfrica News: Malaria - June 25, 2020 Category: Infectious Diseases Source Type: news

Africa: Responding to COVID-19 Must Not Come at the Expense of Malaria Activities, Otherwise Children May Pay The Price
[MSF] MSF paediatrician Carola Buscemi raises concerns about the COVID-19 response interfering with the treatment of measles for children in Sierra Leone. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - June 24, 2020 Category: African Health Source Type: news

Africa: Global Fund COVID-19 Report - Deaths From HIV, TB and Malaria Could Almost Double in 12 Months Unless Urgent Action Is Taken
[Global Fund] Geneva -A new report [ download in English ] released by the Global Fund today estimates that countries affected by HIV, tuberculosis and malaria urgently need US$28.5 billion to protect the extraordinary progress achieved in the fight against the three diseases in the past two decades. (Source: AllAfrica News: HIV-Aids and STDs)
Source: AllAfrica News: HIV-Aids and STDs - June 24, 2020 Category: Infectious Diseases Source Type: news

Africa: Global Fund Ranks in Top Category for Transparency
[Global Fund] The Global Fund to Fight AIDS, Tuberculosis and Malaria was ranked in the top category among organizations and nations that are major donors of global aid for its transparency and accountability, an independent report published on Wednesday showed. (Source: AllAfrica News: HIV-Aids and STDs)
Source: AllAfrica News: HIV-Aids and STDs - June 24, 2020 Category: Infectious Diseases Source Type: news

US Halts Trial of Hydroxychloroquine for COVID-19 Patients US Halts Trial of Hydroxychloroquine for COVID-19 Patients
The US NIH said on Saturday it has halted a clinical trial of the malaria drug hydroxychloroquine for the treatment of hospitalized COVID-19 patients.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 22, 2020 Category: Consumer Health News Tags: Infectious Diseases News Source Type: news

Uganda: Ministry of Health Launches Mosquito Net Distribution
[Independent (Kampala)] Kampala, Uganda -The Ministry of Health has launched the distribution exercise of free mosquito nets across the country. The exercise will start next week until the end of the year. (Source: AllAfrica News: Malaria)
Source: AllAfrica News: Malaria - June 18, 2020 Category: Infectious Diseases Source Type: news

WHO halts trial of hydroxychloroquine in COVID-19 patients
The World Health Organization said on Wednesday that testing of the malaria drug hydroxychloroquine in its large multi-country trial of treatments for COVID-19 patients had been halted after results from other trials showed no benefit. (Source: Reuters: Health)
Source: Reuters: Health - June 17, 2020 Category: Consumer Health News Tags: healthNews Source Type: news

Angola: People Urged to Take Preventive Measures Against Malaria
[ANGOP] Dundo -The health authorities of the eastern Lunda Norte province have urged the population not to neglect prevention measures against malaria and other diseases because of COVID- 19. (Source: AllAfrica News: Malaria)
Source: AllAfrica News: Malaria - June 17, 2020 Category: Infectious Diseases Source Type: news

Some Amazon villagers eschew drugs for COVID-19, take 'toothache plant' herbal tea
Some villagers in the eastern Amazon are spurning Brazilian government advice to take the malaria drug hydroxychloroquine to keep the novel coronavirus at bay and are drinking tea of jamb ú, also known as the toothache plant. (Source: Reuters: Health)
Source: Reuters: Health - June 16, 2020 Category: Consumer Health News Tags: healthNews Source Type: news

FDA Warns Against Combination of Malaria Drug and Gilead's Remdesivir FDA Warns Against Combination of Malaria Drug and Gilead's Remdesivir
The US FDA on Monday issued a warning to healthcare providers against administering malaria drug hydroxychloroquine or chloroquine in combination with Gilead Sciences'experimental COVID-19 drug, remdesivir.Reuters Health Information (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - June 16, 2020 Category: Intensive Care Tags: Infectious Diseases News Source Type: news

U.K. Researchers Say They Have Found First Drug that Improves COVID-19 Survival
Researchers in England say they have the first evidence that a drug can improve COVID-19 survival: A steroid called dexamethasone reduced deaths by up to one third in severely ill hospitalized patients. Results were announced Tuesday and researchers said they would publish them soon. The study is a large, strict test that randomly assigned 2,104 patients to get the drug and compared them with 4,321 patients getting only usual care. The drug was given either orally or through an IV. It reduced deaths by 35% in patients who needed treatment with breathing machines and by 20% in those only needing supplemental oxygen. It did ...
Source: TIME: Science - June 16, 2020 Category: Science Authors: MARILYNN MARCHIONE /AP Tags: Uncategorized Source Type: news

FDA ends emergency approval for hydroxychloroquine, condemns people to die from coronavirus
(Natural News) In an apparent act of spite against President Donald Trump, the U.S. Food and Drug Administration (FDA) has withdrawn emergency approval for hydroxychloroquine, the generic anti-malaria drug that many doctors have been prescribing to patients with the Wuhan coronavirus (COVID-19). Citing alleged safety and effectiveness concerns, the FDA revoked authorizations for both hydroxychloroquine... (Source: NaturalNews.com)
Source: NaturalNews.com - June 16, 2020 Category: Consumer Health News Source Type: news

New discovery paves way for next generation malaria vaccine
(Seattle Children's) New findings pave the way for a novel, next generation genetically attenuated parasite (GAP) vaccine against the deadliest form of malaria in humans. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 16, 2020 Category: International Medicine & Public Health Source Type: news

Hydroxychloroquine: US revokes emergency approval of malaria drug for Covid-19
Food and Drug Administration says drug is unlikely to work against coronavirus and notes heart risksCoronavirus – latest updatesUS regulators revoked the emergency authorization for malaria drugs championed by Donald Trump for treating Covid-19, amidgrowing evidence they don ’t work and could cause serious side effects.The Food and Drug Administration (FDA) said on Monday the drugs hydroxychloroquine and chloroquine were unlikely to be effective in treating the coronavirus. Citing reports of heart complications, the agency said the drugs ’ unproven benefits “do not outweigh the known and potential r...
Source: Guardian Unlimited Science - June 16, 2020 Category: Science Authors: Guardian staff and agencies Tags: Coronavirus outbreak US news Health US healthcare Society Science Infectious diseases Medical research World news Source Type: news

FDA Revokes Emergency Coronavirus Use of Malaria Drugs
The agency said that a review of some studies showed that the drugs ’ potential benefits in treating Covid-19 did not outweigh the risks. (Source: NYT Health)
Source: NYT Health - June 15, 2020 Category: Consumer Health News Authors: Katie Thomas Tags: Drugs (Pharmaceuticals) Hydroxychloroquine (Drug) Coronavirus (2019-nCoV) Food and Drug Administration Biomedical Advanced Research and Development Authority Trump, Donald J Tests (Medical) Clinical Trials your-feed-healthcare Source Type: news

FDA warns against combination of malaria drug and Gilead's remdesivir
The U.S. Food and Drug Administration on Monday issued a warning to healthcare providers against administering malaria drug hydroxychloroquine or chloroquine in combination with Gilead Sciences' experimental COVID-19 drug, remdesivir. (Source: Reuters: Health)
Source: Reuters: Health - June 15, 2020 Category: Consumer Health News Tags: healthNews Source Type: news

US revokes emergency use of drugs touted by Trump vs. virus
U.S. regulators are revoking emergency authorization for malaria drugs promoted by President Donald Trump for treating COVID-19 (Source: ABC News: Health)
Source: ABC News: Health - June 15, 2020 Category: Consumer Health News Tags: Health Source Type: news

Trump touts hydroxychloroquine even as U.S. revokes emergency use status
President Donald Trump said on Monday other countries had provided great reports on the effectiveness of malaria drug hydroxychloroquine for treatment of the deadly coronavirus, complaining that only U.S. agencies have failed to grasp its benefit. (Source: Reuters: Health)
Source: Reuters: Health - June 15, 2020 Category: Consumer Health News Tags: healthNews Source Type: news